Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI

CompletedOBSERVATIONAL
Enrollment

14,616

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

January 2, 2021

Study Completion Date

September 1, 2021

Conditions
Contrast-induced Nephropathy
Interventions
PROCEDURE

Percutaneous Coronary Intervention

Percutaneous Coronary Intervention is a catheter based technique widely used to restore coronary vessel patency. It is performed by fluoroscopic guidance and it requires the use of iodinated contrast medium. The use of iodinated contrast media has been historically linked to AKI occurring within days after their administration and typically referred to as CA-AKI. Furthermore, CA-AKI has been associated with long-term impairment of kidney function, need for renal replacement therapy, and subsequent all-cause mortality.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT05132062 - Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI | Biotech Hunter | Biotech Hunter